Serife Ozturk Yilmaz

Serife Ozturk Yilmaz

Auto-generated profile, based on publicly available information

Serife Ozturk Yilmaz

Faculty of Medicine, Department of Pediatric Genetics Dokuz Eylül University İzmir Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2025 in BMC Immunology
Verified
Journal Article
Open access
PDF file
GKGizem Kabadayı
Gizem Kabadayı
ÖAÖzge Atay
Özge Atay
DBDamla Baysal Bakır
Damla Baysal Bakır
HYHalime Yağmur
Halime Yağmur
EMEsma Tuğba Kaşıkçı Mermer
Esma Tuğba Kaşıkçı Mermer
NUNevin Uzuner
Nevin Uzuner
Severe combined immunodeficiency (SCID) is a congenital immunodeficiency characterized by significant numerical or functional defects in T lymphocytes and is often accompanied by B lymphocyte dysfunction. It presents early in life with severe, recurrent opportunistic infections. Early diagnosis and hematopoietic stem cell transplantation (HSCT) are vital for patient survival. Cernunnos/XLF deficiency is an autosomal recessive form of SCID caused by mutations in the NHEJ1 gene, which plays a critical role in repairing DNA double-strand breaks. First described in 2006, this condition remains exceedingly rare, with only about 55 cases reported to date. This study aimed to describe a novel infant with Cernunnos/XLF deficiency and to review previously reported patients carrying the same variant, thereby expanding the clinical spectrum of this rare disease. With written informed consent, we retrospectively evaluated a pediatric patient with Cernunnos/XLF deficiency followed at our clinic. Demographic, clinical, laboratory, and radiological findings were reviewed. The diagnosis was based on clinical and immunological features and confirmed via clinical exome sequencing. A literature review was conducted to compare the genotype–phenotype correlations of previously reported patients carrying the same NHEJ1 variant. We report an infant who was hospitalized at 6.5 months of age with a preliminary diagnosis of meningitis and was subsequently diagnosed with Cernunnos/XLF deficiency. The patient exhibited microcephaly, growth retardation, recurrent infections, prolonged SARS-CoV-2 PCR positivity, and localized BCGitis following live Bacillus Calmette–Guérin (BCG) vaccination. Immunological evaluation revealed T- and B-cell lymphopenia and hypogammaglobulinemia. Genetic testing confirmed a homozygous nonsense mutation in NHEJ1. HSCT from a matched sibling donor was performed. This study describes a rare case of Cernunnos/XLF deficiency diagnosed in early infancy, underscoring the value of early recognition and the critical role of genetic testing and HSCT. It also expands the clinical spectrum of the disease and provides a comparative perspective with previously reported patients carrying the same mutation. In infants presenting with unexplained infections or complications related to live vaccines, inborn errors of immunity should be considered. Our findings emphasize the importance of timely diagnosis and comprehensive, multidisciplinary follow-up, particularly in patients with additional complications.

10 July 2026 in Molecular Syndromology
Verified
Journal Article
Closed access
SYSerife Ozturk Yilmaz
Serife Ozturk Yilmaz
MKMehmet Kocabey
Mehmet Kocabey
HSHuseyin Bahadir Senol
Huseyin Bahadir Senol
SGSemra Gursoy
Semra Gursoy
AHAyse Semra Hız
Ayse Semra Hız
OBOzlem Giray Bozkaya
Ozlem Giray Bozkaya
Introduction: Genes involved in tRNA modification are critical contributors to a broad range of human neurodevelopmental disorders, reflecting the essential role of RNA modifications in brain development and function. The THUMPD1 gene plays a key role in tRNA modification, and biallelic loss-of-function variants in this gene are known to cause Neurodevelopmental Disorder with Speech Delay and Variable Ocular Anomalies (NEDSOA), an autosomal-recessive condition. Case Presentation: We report two sisters harboring a novel homozygous frameshift variant in THUMPD1(NM_017736.5):c.311del;p.(Gly104ValfsTer9), who presented with global developmental delay, severe speech impairment, and ocular anomalies. One affected individual also exhibited severe unilateral skeletal abnormalities on the left hand, including aplasia of the middle and distal phalanges of the fourth finger and the middle phalanx of the fifth finger. To our knowledge, this skeletal feature has not previously been reported in a patient with THUMPD1-related neurodevelopmental disorder. Conclusion: Although this skeletal anomaly contributes to the clinical description of the present family, the presence of the finding in only 1 of the 2 affected siblings, both of whom carry the same homozygous variant, limits the strength of the genotype-phenotype association. Therefore, a definitive causal relationship between the THUMPD1 variant and the skeletal phenotype cannot be established, and confirmation in additional individuals will be required.

5 April 2026 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
SYSerife Ozturk Yilmaz
Serife Ozturk Yilmaz
AYAyca Yigit
Ayca Yigit
SHSevcan Hatipoglu
Sevcan Hatipoglu
SGSemra Gürsoy
Semra Gürsoy
AGAytac Gulcu
Aytac Gulcu
OBOzlem Giray Bozkaya
Ozlem Giray Bozkaya